Please enable JavaScript to continue using this application.

Compare $IMRX vs $PYXS | Chartloom

Compare

$IMRX vs $PYXS

Immuneering Corp · Pyxis Oncology Inc

IMRX

Immuneering Corp

PYXS

Pyxis Oncology Inc

Compare $IMRX vs $PYXS

Comparing Immuneering Corp and Pyxis Oncology Inc

IMRXImmuneering Corp

PYXSPyxis Oncology Inc

IMRXImmuneering Corp

Market cap

$255M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.5%

52W performance

-39.4%

FCF yield

-22.4%

PYXSPyxis Oncology Inc

Market cap

$168M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-14.2%

YTD performance

76.5%

52W performance

-30.2%

FCF yield

-40.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMRX

PYXS

Detailed metrics comparison

IMRX

Immuneering Corp

PYXS

Pyxis Oncology Inc

Market Cap

IMRX$255M

PYXS$168M

Enterprise Value

IMRX$214M

PYXS$150M

Price

IMRX$3.94

PYXS$2.03

P/E Ratio

IMRXN/A

PYXSN/A

P/S Ratio

IMRX526.64x

PYXS15.26x

EV/Sales

IMRX443.99x

PYXS13.55x

EV/EBITDA

IMRX0.00x

PYXS0.00x

P/B Ratio

IMRX1.38x

PYXS15.60x

P/FCF Ratio

IMRXN/A

PYXSN/A

EV/FCF

IMRX-3.75x

PYXS-2.20x

PEG Ratio

IMRXN/A

PYXSN/A

Forward P/E (NTM)

IMRXN/A

PYXSN/A

Forward P/S (NTM)

IMRXN/A

PYXSN/A

Revenue (TTM)

IMRX$0

PYXS$11M

Revenue Growth (YoY)

IMRXN/A

PYXS-14.2%

Forward Rev Growth

IMRX100.5%

PYXS14187.3%

Gross Margin (TTM)

IMRX28.0%

PYXS78.4%

Operating Margin (TTM)

IMRX0.0%

PYXS0.0%

EBITDA Margin (TTM)

IMRX0.0%

PYXS-580.0%

Net Margin (TTM)

IMRX0.0%

PYXS-593.0%

FCF Margin (TTM)

IMRXN/A

PYXS-615.3%

Net Income (TTM)

IMRX$-57M

PYXS$-65M

FCF (TTM)

IMRX$-57M

PYXS$-68M

EPS (TTM)

IMRX-$0.89

PYXS-$1.03

ROE (TTM)

IMRX-2715.0%

PYXS-10177.0%

ROA (TTM)

IMRX-2574.0%

PYXS-6981.0%

ROIC (TTM)

IMRX-2715.0%

PYXS-10171.0%

Cash

IMRX$41M

PYXS$19M

Debt

IMRX$0

PYXS$0

Net Cash/Debt

IMRX$41M

PYXS$19M

Current Ratio (TTM)

IMRX19.47x

PYXS1.34x

Quick Ratio (TTM)

IMRX18.47x

PYXS1.25x

Debt/Equity (TTM)

IMRX0.00x

PYXS0.00x

Debt/Assets (TTM)

IMRX0.0%

PYXS0.0%

Interest Coverage (TTM)

IMRXN/A

PYXSN/A

Net Debt/EBITDA (TTM)

IMRX0.00x

PYXS0.00x

Beta

IMRX0.34

PYXS1.37

52W Performance

IMRX-39.4%

PYXS-30.2%

YTD Performance

IMRX-40.5%

PYXS76.5%

% from 52W High

IMRX-53.5%

PYXS-63.4%

% from 52W Low

IMRX9.4%

PYXS97.1%

Asset Turnover (TTM)

IMRX0.00x

PYXS0.00x

FCF Yield (TTM)

IMRX-22.4%

PYXS-40.3%

Earnings Yield (TTM)

IMRX-22.5%

PYXS-38.9%

Dividend Yield (TTM)

IMRXN/A

PYXSN/A

Rule of 40

IMRX0.0

PYXS-629.5

EV/GP/RG

IMRXN/A

PYXS0.00

Ticker research

View IMRX research View PYXS research

Metric	IMRX Immuneering Corp	PYXS Pyxis Oncology Inc
Market & Valuation
Market Cap	$255M	$168M
Enterprise Value	$214M	$150M
Price	$3.94	$2.03
P/E Ratio	N/A	N/A
P/S Ratio	526.64x	15.26x
EV/Sales	443.99x	13.55x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.38x	15.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	-2.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$11M
Revenue Growth (YoY)	N/A	-14.2%
Forward Rev Growth	100.5%	14187.3%
Profitability
Gross Margin (TTM)	28.0%	78.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-580.0%
Net Margin (TTM)	0.0%	-593.0%
FCF Margin (TTM)	N/A	-615.3%
Net Income (TTM)	$-57M	$-65M
FCF (TTM)	$-57M	$-68M
EPS (TTM)	-$0.89	-$1.03
ROE (TTM)	-2715.0%	-10177.0%
ROA (TTM)	-2574.0%	-6981.0%
ROIC (TTM)	-2715.0%	-10171.0%
Financial Health
Cash	$41M	$19M
Debt	$0	$0
Net Cash/Debt	$41M	$19M
Current Ratio (TTM)	19.47x	1.34x
Quick Ratio (TTM)	18.47x	1.25x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	1.37
52W Performance	-39.4%	-30.2%
YTD Performance	-40.5%	76.5%
% from 52W High	-53.5%	-63.4%
% from 52W Low	9.4%	97.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-22.4%	-40.3%
Earnings Yield (TTM)	-22.5%	-38.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-629.5
EV/GP/RG	N/A	0.00
Ticker research	View IMRX research	View PYXS research

Valuation

P/S Ratio

PYXS

15.26x

IMRX

526.64x

EV/FCF

IMRX

-3.75x

PYXS

-2.20x

Growth & revenue

Revenue Growth TTM

PYXS

-14.2%

Forward Revenue Growth

PYXS

14187.3%

IMRX

100.5%

Profitability & performance

Gross Margin

PYXS

78.4%

IMRX

28.0%

ROE

IMRX

-2715.0%

PYXS

-10177.0%

FCF Yield %

IMRX

-22.4%

PYXS

-40.3%

52-Week Performance

PYXS

-30.2%

IMRX

-39.4%

Detailed metrics comparison

IMRX

Immuneering Corp

PYXS

Pyxis Oncology Inc

Market Cap

IMRX$255M

PYXS$168M

Enterprise Value

IMRX$214M

PYXS$150M

Price

IMRX$3.94

PYXS$2.03

P/E Ratio

IMRXN/A

PYXSN/A

P/S Ratio

IMRX526.64x

PYXS15.26x

EV/Sales

IMRX443.99x

PYXS13.55x

EV/EBITDA

IMRX0.00x

PYXS0.00x

P/B Ratio

IMRX1.38x

PYXS15.60x

P/FCF Ratio

IMRXN/A

PYXSN/A

EV/FCF

IMRX-3.75x

PYXS-2.20x

PEG Ratio

IMRXN/A

PYXSN/A

Forward P/E (NTM)

IMRXN/A

PYXSN/A

Forward P/S (NTM)

IMRXN/A

PYXSN/A

Revenue (TTM)

IMRX$0

PYXS$11M

Revenue Growth (YoY)

IMRXN/A

PYXS-14.2%

Forward Rev Growth

IMRX100.5%

PYXS14187.3%

Gross Margin (TTM)

IMRX28.0%

PYXS78.4%

Operating Margin (TTM)

IMRX0.0%

PYXS0.0%

EBITDA Margin (TTM)

IMRX0.0%

PYXS-580.0%

Net Margin (TTM)

IMRX0.0%

PYXS-593.0%

FCF Margin (TTM)

IMRXN/A

PYXS-615.3%

Net Income (TTM)

IMRX$-57M

PYXS$-65M

FCF (TTM)

IMRX$-57M

PYXS$-68M

EPS (TTM)

IMRX-$0.89

PYXS-$1.03

ROE (TTM)

IMRX-2715.0%

PYXS-10177.0%

ROA (TTM)

IMRX-2574.0%

PYXS-6981.0%

ROIC (TTM)

IMRX-2715.0%

PYXS-10171.0%

Cash

IMRX$41M

PYXS$19M

Debt

IMRX$0

PYXS$0

Net Cash/Debt

IMRX$41M

PYXS$19M

Current Ratio (TTM)

IMRX19.47x

PYXS1.34x

Quick Ratio (TTM)

IMRX18.47x

PYXS1.25x

Debt/Equity (TTM)

IMRX0.00x

PYXS0.00x

Debt/Assets (TTM)

IMRX0.0%

PYXS0.0%

Interest Coverage (TTM)

IMRXN/A

PYXSN/A

Net Debt/EBITDA (TTM)

IMRX0.00x

PYXS0.00x

Beta

IMRX0.34

PYXS1.37

52W Performance

IMRX-39.4%

PYXS-30.2%

YTD Performance

IMRX-40.5%

PYXS76.5%

% from 52W High

IMRX-53.5%

PYXS-63.4%

% from 52W Low

IMRX9.4%

PYXS97.1%

Asset Turnover (TTM)

IMRX0.00x

PYXS0.00x

FCF Yield (TTM)

IMRX-22.4%

PYXS-40.3%

Earnings Yield (TTM)

IMRX-22.5%

PYXS-38.9%

Dividend Yield (TTM)

IMRXN/A

PYXSN/A

Rule of 40

IMRX0.0

PYXS-629.5

EV/GP/RG

IMRXN/A

PYXS0.00

Ticker research

View IMRX research View PYXS research

Metric	IMRX Immuneering Corp	PYXS Pyxis Oncology Inc
Market & Valuation
Market Cap	$255M	$168M
Enterprise Value	$214M	$150M
Price	$3.94	$2.03
P/E Ratio	N/A	N/A
P/S Ratio	526.64x	15.26x
EV/Sales	443.99x	13.55x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.38x	15.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	-2.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$11M
Revenue Growth (YoY)	N/A	-14.2%
Forward Rev Growth	100.5%	14187.3%
Profitability
Gross Margin (TTM)	28.0%	78.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-580.0%
Net Margin (TTM)	0.0%	-593.0%
FCF Margin (TTM)	N/A	-615.3%
Net Income (TTM)	$-57M	$-65M
FCF (TTM)	$-57M	$-68M
EPS (TTM)	-$0.89	-$1.03
ROE (TTM)	-2715.0%	-10177.0%
ROA (TTM)	-2574.0%	-6981.0%
ROIC (TTM)	-2715.0%	-10171.0%
Financial Health
Cash	$41M	$19M
Debt	$0	$0
Net Cash/Debt	$41M	$19M
Current Ratio (TTM)	19.47x	1.34x
Quick Ratio (TTM)	18.47x	1.25x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	1.37
52W Performance	-39.4%	-30.2%
YTD Performance	-40.5%	76.5%
% from 52W High	-53.5%	-63.4%
% from 52W Low	9.4%	97.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-22.4%	-40.3%
Earnings Yield (TTM)	-22.5%	-38.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-629.5
EV/GP/RG	N/A	0.00
Ticker research	View IMRX research	View PYXS research